Infection Control and Hospital Epidemiology · 2000 · 155 citations · 11 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial StewardshipMedical MicrobiologyAntibiotic ResistanceAntibiotic Resistance MechanismsAntimicrobial Resistance PreventionHospital Antimicrobial StewardshipMultidrug ResistanceResistance EpidemiologyAntibiotic Utilization MeasurementAntimicrobial Utilization EvaluationHospital Antimicrobial UtilizationImplementation Of Contact PrecautionsKlebsiella Pneumoniae ResistancePhysician Continuing Medical EducationPulsed-field Gel ElectrophoresisUtilization Measures
OBJECTIVE: To study the association of antibiotic-utilization measures and control of multidrug-resistant (MDR) Klebsiella pneumoniae after emergence in two hospitals in our medical center. DESIGN AND SETTING: Rates of MDR K. pneumoniae at two hospitals were compared before and after acute interventions, including emphasis on Contact Precautions and education in antibiotic utilization. Antipseudomonal beta-lactam antibiotic use was measured before and after the interventions at both hospitals. Pulsed-field gel electrophoresis of whole cell DNA was used as a marker of strain identity. RESULTS: Clonal strain dissemination was the major mechanism of emergence at hospital A; emergence was polyclonal at hospital B. Antibiotic-utilization interventions at both institutions included physician education regarding the association of ceftazidime use and MDR K. pneumoniae. At hospital A, ceftazidime use decreased from 4,301 g in the preintervention period, to 1,248 g in the postintervention period. Piperacillin-tazobactam use increased from 12,455 g to 17,464 g. Ceftazidime resistance in K. pneumoniae decreased from 110 (22%) of 503 isolates to 61 (15%) of 407 isolates (P<.05); piperacillin-tazobactam resistance decreased from 181 (36%) of 503 to 77 (19%) of 407 isolates (P<.05). At hospital B, ceftazidime use decreased from 6,533 g in the preintervention period to 4,792 g in the postintervention period. Piperacillin-tazobactam use increased from 58,691 g to 67,027 g. Ceftazidime resistance in K. pneumoniae decreased from 42 (10%) of 415 isolates to 19 (5%) of 383 isolates (P<.05). Piperacillin-tazobactam resistance decreased from 91 (22%) of 415 isolates to 54 (14%) of 383 isolates (P<.05). Follow-up data showed continued decrease in piperacillin-tazobactam resistance despite increased use at both hospitals. CONCLUSIONS: Antibiotic-use measures may be particularly important for control of MDR K. pneumoniae, whether emergence is clonal or polyclonal.
11
Vincent Jarlier, M. H. Nicolas, G. Fournier et al. · Clinical Infectious Diseases · 1988 · 1.6K citations
Louis B. Rice, Sandra Willey, Genovefa A. Papanicolaou et al. · Antimicrobial Agents and Chemotherapy · 1990 · 383 citations · Full text
Louis B. Rice, Elizabeth C. Eckstein, James DeVente et al. · Clinical Infectious Diseases · 1996 · 316 citations · Full text
Édouard Bingen, P Desjardins, Guillaume Arlet et al. · Journal of Clinical Microbiology · 1993 · 129 citations · Full text